The expression of CXCL5 and KIF2A was upregulated in various cancer tissues, including cervical cancer [24,25,27,38]; additionally, the expression of RGS18 in the tissues of patients with ovarian cancer was also upregulated [30]. This evidence concerns the gene KIF2A and ovarian carcinoma.